Imunon, Inc. Shares Issued, Shares, Share-based Payment Arrangement, before Forfeiture
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Imunon, Inc. shares issued, shares, share-based payment arrangement, before forfeiture for the quarter ending 2015-09-30 was -78.57K shares.
- Imunon, Inc. shares issued, shares, share-based payment arrangement, before forfeiture for the quarter ending 2015-06-30 was -104.44K shares.
- Imunon, Inc. shares issued, shares, share-based payment arrangement, before forfeiture for the quarter ending 2015-03-31 was 2.40M shares.
| Period end | Shares Issued, Shares, Share-based Payment Arrangement, before Forfeiture 3 month | Shares Issued, Shares, Share-based Payment Arrangement, before Forfeiture 12 month |
|---|---|---|
| 2015-09-30 | -78.57K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | |
| 2015-06-30 | -104.44K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | |
| 2015-03-31 | 2.40M shares 10-Q · filed 2015-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |